The Center for Drug Evaluation (CDE) performs regulatory evaluation of new drugs and medical devices to assess if these can be brought to the market in China. Our multi-dose eye...Continue Reading
SciGen receives approval from Australian Register of Therapeutic Goods, for Nemera’s reusable pen injector, for its human growth hormone.
SciTropin A™ Pen is a state-of-the-art pen injector device manufactured by Nemera. It was included in the ARTG in February 2022 opening the way for the device to be distributed...Continue Reading
Yesterday, we laid the first stone of our new state-of-the-art manufacturing facility in Szczecin, Poland. This facility will help extend our manufacturing capabilities and bring more drug delivery device solutions...Continue Reading
Nemera metering dose pump and actuator for Flonase Allergy Relief has been approved by the U.S. FDA Nemera, one of the world leaders in the design, development and manufacturing ...Continue Reading
Nemera awarded silver medal in the EcoVadis sustainability assessment, figuring in the top 22% of all companies evaluated.
Nemera awarded silver medal in the EcoVadis sustainability assessment, figuring in the top 22% of all companies evaluated. At Nemera we are committed to conducting business in an ethical and...Continue Reading
This acquisition strengthens Nemera’s proprietary product offering and establishes operations footprint in Eastern Europe. Nemera today announced that they have entered into an agreement to acquire Copernicus. Copernicus, based ...Continue Reading